Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
CARDIOTHORACIC	O
Allergies:	O
Amoxicillin	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Critical	O
Aortic	O
Stenosis,	O
evaluate	O
for	O
AVR	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
___	O
left	O
and	O
right	O
heart	O
catheterization	O
___	O
1.	O
Aortic	O
valve	O
replacement	O
with	O
a	O
21-mm	O
___	O
Ease	O
aortic	O
valve	O
bioprosthesis	O
(model	O
number	O
___,	O
serial	O
number	O
___.	O
2.	O
Aortic	O
patch	O
closure	O
with	O
bovine	O
pericardium.	O
Pericardium	O
data	O
--	O
reference	O
number	O
___,	O
lot	O
number	O
___.	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
an	O
___	O
female	O
with	O
a	O
history	O
of	O
critical	O
aortic	O
stenosis,	O
systolic	O
congestive	O
heart	O
failure,	O
and	O
deconditioning	O
due	O
to	O
arthritis,	O
who	O
presented	O
to	O
___	O
on	O
___	O
with	O
shortness	O
of	O
breath	O
and	O
dyspnea	O
on	O
exertion.	O
At	O
the	O
time	O
of	O
presentation	O
she	O
was	O
unable	O
to	O
walk	O
more	O
than	O
10	O
feet	O
without	O
dyspnea.	O
These	O
symptoms	O
were	O
suspected	O
to	O
be	O
due	O
a	O
CHF	O
exacerbation	O
from	O
her	O
critical	O
AS.	O
This	O
was	O
her	O
second	O
CHF	O
exacerbation	O
with	O
the	O
first	O
being	O
in	O
___	O
when	O
she	O
was	O
first	O
diagnosed	O
with	O
AS.	O
She	O
has	O
never	O
had	O
angina	O
or	O
syncope	O
however	O
she	O
has	O
had	O
lower	O
energy	O
level	O
for	O
at	O
least	O
a	O
year	O
that	O
she	O
was	O
not	O
able	O
to	O
explain.	O
At	O
the	O
OSH	O
she	O
was	O
diuresed	O
with	O
IV	O
Lasix.	O
She	O
was	O
transferred	O
to	O
___	O
for	O
cath	O
and	O
further	O
evaluation	O
of	O
her	O
severe	O
AF.	O
Of	O
note,	O
she	O
was	O
also	O
complaining	O
of	O
URI	O
symptoms	O
which	O
resolved	O
during	O
that	O
admission,	O
except	O
for	O
persistent	O
cough.	O
She	O
did	O
not	O
have	O
any	O
fevers	O
or	O
chills.	O
Cardiac	O
surgery	O
was	O
consulted	O
for	O
evaluation	O
of	O
operative	O
candidacy	O
for	O
aortic	O
valve	O
replacement.	O
Past	O
Medical	O
History:	O
Critical	O
aortic	O
stenosis-	O
Aortic	O
Valve	O
Replacement	O
PMH:	O
Moderate	O
to	O
severe	O
osteoarthritis	O
Likely	O
ischemic	O
cardiomyopathy,	O
EF	O
of	O
40-45%	O
Moderate	O
aortic	O
regurgitation	O
and	O
mild	O
MR	O
___	O
pulmonary	O
artery	O
hypertension	O
Hypertension	O
Hyperlipidemia	O
Scarlet	O
fever	O
at	O
the	O
age	O
of	O
___	O
Chronic	O
left	O
leg	O
edema	O
for	O
several	O
years,	O
after	O
3	O
attacks	O
of	O
cellulitis	O
___	O
years	O
apart	O
Anxiety	O
disorder	O
Chronic	O
kidney	O
disease	O
stage	O
III,	O
baseline	O
creatinine	O
1.2	O
Neuropathy	O
in	O
bilateral	O
hands	O
s/p	O
fall	B-Falls
___	O
years	O
ago	O
Chronic	O
urinary	O
urgency	O
Past	O
Surgical	O
History:	O
Bilateral	O
total	O
knee	O
replacement.	O
Left	O
shoulder	O
replacement.	O
Surgery	O
for	O
cervical	O
spondylosis.	O
Bilateral	O
Carpal	O
tunnel	O
surgery	O
Right	O
cataract	B-Visual_impairment
surgery	O
Appendectomy	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
died	O
of	O
MI	O
at	O
___	O
Mother	O
died	O
of	O
ADPKD	O
at	O
age	O
___	O
No	O
family	O
history	O
of	O
early	O
MI,	O
arrhythmia,	O
cardiomyopathies,	O
or	O
sudden	O
cardiac	O
death;	O
otherwise	O
non-contributory.	O
Physical	O
Exam:	O
On	O
Admission:	O
VS:	O
99.4	O
___	O
22	O
97%	O
on	O
2L	O
GENERAL:	O
WDWN	O
female	O
in	O
NAD.	O
Oriented	B-Delirium
x3.	B-Delirium
Mood,	O
affect	O
appropriate.	O
HEENT:	O
NCAT.	O
Sclera	O
anicteric.	O
PERRL,	O
EOMI.	O
Conjunctiva	O
were	O
pink,	O
no	O
pallor	O
or	O
cyanosis	O
of	O
the	O
oral	O
mucosa.	O
No	O
xanthalesma.	O
NECK:	O
Supple	O
with	O
JVP	O
of	O
7cm	O
CARDIAC:	O
PMI	O
located	O
in	O
___	O
intercostal	O
space,	O
midclavicular	O
line.	O
RR,	O
___	O
crescendo/decrescendo	O
systolic	O
murmur	O
that	O
radiates	O
to	O
carotids.	O
No	O
heave.	O
No	O
S4.	O
LUNGS:	O
Diffuse	O
expiratory	O
wheeze	O
ABDOMEN:	O
Soft,	O
NTND.	O
No	O
HSM	O
or	O
tenderness.	O
Abd	O
aorta	O
not	O
enlarged	O
by	O
palpation.	O
No	O
abdominial	O
bruits.	O
EXTREMITIES:	O
2+	O
pitting	O
edema	O
in	O
LLE,	O
1+	O
pitting	O
edema	O
in	O
RLE	O
SKIN:	O
No	O
stasis	O
dermatitis,	O
ulcers,	B-Pressure_injury
scars,	O
or	O
xanthomas.	O
PULSES:	O
Right:	O
Carotid	O
2+	O
Femoral	O
2+	O
Popliteal	O
2+	O
DP	O
2+	O
___	O
2+	O
Left:	O
Carotid	O
2+	O
Femoral	O
2+	O
Popliteal	O
2+	O
DP	O
2+	O
___	O
2+	O
Pertinent	O
Results:	O
ADMISSION	O
LABS	O
==============	O
___	O
09:25AM	O
BLOOD	O
WBC-6.2	O
RBC-3.88*	O
Hgb-11.7*	O
Hct-34.8*	O
MCV-90	O
MCH-30.1	O
MCHC-33.6	O
RDW-12.4	O
Plt	O
___	O
___	O
03:24AM	O
BLOOD	O
Glucose-128*	O
UreaN-27*	O
Creat-1.1	O
Na-135	O
K-4.1	O
Cl-97	O
HCO3-32	O
AnGap-10	O
___	O
09:25AM	O
BLOOD	O
ALT-24	O
AST-16	O
AlkPhos-76	O
TotBili-0.4	O
___	O
06:05AM	O
BLOOD	O
___	O
___	O
03:24AM	O
BLOOD	O
Mg-1.4*	O
___	O
09:25AM	O
BLOOD	O
%HbA1c-6.4*	O
eAG-137*	O
DISCHARGE	O
LABS	O
==============	O
IMAGING	O
==============	O
Prelim	O
Cath	O
Report	O
___:	O
1)	O
Selective	O
coronary	O
angiography	O
of	O
this	O
right-dominant	O
system	O
demonstrated	O
insignificant	O
coronary	O
artery	O
disease.	O
The	O
LMCA	O
was	O
free	O
of	O
flow-limiting	O
stenoses.	O
The	O
LAD	O
had	O
a	O
50%	O
mid-to-distal	O
stenosis;	O
there	O
was	O
also	O
a	O
50%	O
stenosis	O
at	O
the	O
origin	O
of	O
the	O
diagonal	O
branch.	O
The	O
LCx	O
was	O
free	O
of	O
flow-limiting	O
stenoses.	O
The	O
large	O
dominant	O
RCA	O
had	O
a	O
___	O
stenosis	O
in	O
the	O
proximal	O
portion	O
of	O
the	O
vessel.	O
2)	O
Supravalvular	O
aortography	O
demonstrated	O
1+	O
aortic	O
regurgitation.	O
The	O
sinus	O
of	O
Valsalva	O
width	O
was	O
25-27mm	O
in	O
diameter.	O
3)	O
Distal	O
abdominal	O
aortography	O
demonstrated	O
patency	O
of	O
the	O
left	O
iliac	O
artery	O
(diameter	O
>7mm)	O
and	O
an	O
accordion	O
effect	O
of	O
the	O
right	O
iliac	O
artery,	O
due	O
to	O
vessel	O
tortuosity.	O
4)	O
Limited	O
resting	O
hemodynamics	O
revealed	O
markedly	O
elevated	O
left-sided	O
filling	O
pressures,	O
with	O
a	O
mean	O
wedge	O
pressure	O
of	O
35	O
mmHg,	O
and	O
marked	O
pulmonary	O
arterial	O
hypertension,	O
with	O
a	O
PA	O
systolic	O
pressure	O
of	O
75	O
mmHg	O
and	O
a	O
mean	O
PA	O
pressure	O
of	O
49	O
mmHg.	O
These	O
findings	O
are	O
consistent	O
with	O
aortic	O
stenosis.	O
There	O
was	O
also	O
marked	O
systemic	O
arterial	O
hypertension,	O
with	O
a	O
central	O
aortic	O
pressure	O
of	O
188/80	O
mmHg.	O
5)	O
Estimated	O
cardiac	O
index	O
by	O
___	O
principle	O
was	O
normal	O
at	O
2.4-2.6	O
l/min/m2.	O
FINAL	O
DIAGNOSIS:	O
1.	O
Critical	O
aortic	O
stenosis	O
with	O
markedly-elevated	O
wedge	O
pressure.	O
2.	O
Insignificant	O
coronary	O
artery	O
disease.	O
3.	O
Evaluate	O
for	O
aortic	O
valve	O
replacement	O
surgery.	O
In	O
the	O
meantime,	O
would	O
recommend	O
diuresis	O
and	O
volume	O
status	O
optimization.	O
.	O
CT	O
chest	O
w/o	O
contrast	O
___:	O
1.	O
Bilateral	O
pleural	O
effusions,	O
moderate.	O
Left	O
lower	O
lobe	O
consolidation	O
that	O
potentially	O
may	O
represent	O
atelectasis,	O
although	O
infectious	O
process	O
cannot	O
be	O
entirely	O
excluded.	O
Neoplasm	O
is	O
substantially	O
less	O
likely,	O
but	O
follow-up	O
in	O
8	O
weeks	O
or	O
comparison	O
with	O
prior	O
studies	O
is	O
recommended.	O
2.	O
Retrosternal	O
component	O
of	O
large	O
thyroid	O
goiter,	O
approximately	O
7	O
cm	O
below	O
the	O
thoracic	O
inlet.	O
3.	O
Extensive	O
coronary	O
calcifications	O
and	O
aortic	O
valve	O
calcifications.	O
4.	O
Compression	B-Vertebral_compression_fracture
fracture	B-Vertebral_compression_fracture
of	O
lower	O
thoracic	B-Vertebral_compression_fracture
vertebral	B-Vertebral_compression_fracture
body,	B-Vertebral_compression_fracture
most	O
likely	O
T11.	B-Vertebral_compression_fracture
.	O
Carotid	O
Doppler	O
___:	O
Right	O
ICA	O
<40%	O
stenosis.	O
Left	O
ICA	O
<40%	O
stenosis.	O
.	O
Panorex	O
___:	O
Technically	O
limited	O
film.	O
Questionable	O
slight	O
resorption	O
of	O
bone	O
surrounding	O
the	O
radix	O
of	O
___.	O
No	O
other	O
evidence	O
of	O
periradicular	O
granulomas	O
.	O
___	O
Intra-op	O
TEE	O
Conclusions	O
There	O
is	O
moderate	O
symmetric	O
left	O
ventricular	O
hypertrophy.	O
Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
low	O
normal	O
(LVEF	O
50-55%).	O
Right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
with	O
mild	O
global	O
free	O
wall	O
hypokinesis.	O
There	O
are	O
simple	O
atheroma	O
in	O
the	O
ascending	O
aorta	O
and	O
complex	O
(mobile)	O
atheroma	O
in	O
the	O
descending	O
aorta.	O
A	O
bioprosthetic	O
aortic	O
valve	O
prosthesis	O
is	O
present.	O
The	O
aortic	O
valve	O
prosthesis	O
appears	O
well	O
seated,	O
with	O
normal	O
leaflet/disc	O
motion	O
and	O
transvalvular	O
gradients.	O
Trace	O
paravalvular	O
leak	O
is	O
seen.	O
There	O
is	O
trace	O
aortic	O
regurgitation.	O
There	O
is	O
echodense	O
material	O
around	O
the	O
aortic	O
bioprosthesis	O
however	O
without	O
blood	O
flow	O
into	O
the	O
echodense	O
space	O
consistent	O
with	O
normal	O
postoperative	O
changes.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
structurally	O
normal.	O
Trivial	O
mitral	O
regurgitation	O
is	O
seen.	O
There	O
is	O
a	O
very	O
small	O
pericardial	O
effusion	O
with	O
no	O
signs	O
of	O
tamponade.	O
IMPRESSION:	O
Normal	O
bioprosthetic	O
valve	O
function.	O
Moderate	O
symmetric	O
left	O
ventricular	O
hypertrophy	O
with	O
borderline	O
left	O
ventricular	O
hypokinesis.	O
Basal	O
to	O
mid	O
septal	O
hypokinesis.	O
Mild	O
global	O
right	O
ventricular	O
hypokinesis.	O
In	O
comparison	O
to	O
the	O
post-AVR	O
intra-operative	O
TEE	O
from	O
earlier	O
today,	O
the	O
findings	O
are	O
similar.	O
Dr.	O
___	O
was	O
notified	O
in	O
person	O
of	O
the	O
results.	O
Electronically	O
signed	O
by	O
___,	O
MD,	O
Interpreting	O
physician	O
___	O
___	O
12:07	O
Brief	O
Hospital	O
Course:	O
MEDICINE	O
COURSE:	O
___	O
female	O
who	O
has	O
critical	O
aortic	O
stenosis	O
who	O
presented	O
to	O
OSH	O
with	O
CHF	O
exacerbation	O
and	O
was	O
transferred	O
to	O
___	O
for	O
management	O
of	O
her	O
AS	O
.	O
ACTIVE	O
ISSUES:	O
==============	O
#	O
Acute	O
on	O
Chronic	O
Heart	O
Failure	O
due	O
to	O
Critical	O
Aortic	O
Stenosis:	O
-	O
Will	O
undergo	O
AVR	O
on	O
___	O
-	O
Patient	O
improving	O
with	O
diuresis	O
down	O
to	O
89.4kg	O
(197	O
lbs)	O
from	O
213lbs	O
on	O
presentation	O
to	O
OSH.	O
Transitioned	O
to	O
PO	O
lasix	O
40mg	O
daily	O
-	O
continued	O
home	O
dose	O
of	O
metoprolol	O
.	O
#	O
Cough/Wheeze:	O
PFTs	O
consistent	O
with	O
obstructive	O
pattern.	O
Possibly	O
related	O
to	O
CHF	O
(cardiac	O
asthma).	O
Patient	O
has	O
no	O
history	O
of	O
asthma	O
or	O
COPD	O
and	O
only	O
minimal	O
smoking	O
history.	O
ABG	O
on	O
room	O
air	O
showed	O
metabolic	O
alkalosis	O
(likely	O
contraction	O
alkalosis	O
from	O
diuresis).	O
No	O
evidence	O
of	O
chronic	O
C02	O
retention.	O
-	O
Treatment	O
of	O
CHF	O
as	O
above.	O
.	O
CHRONIC	O
ISSUES:	O
===============	O
#	O
CKD:	O
Creatinine	O
at	O
baseline	O
(1.1-1.3	O
per	O
report)	O
.	O
TRANSITIONAL	O
ISSUES	O
===================	O
-	O
Patient	O
will	O
need	O
8	O
week	O
chest	O
xray	O
to	O
evaluate	O
left	O
lower	O
lobe	O
consolidation	O
seen	O
on	O
CT	O
chest	O
___	O
-	O
Patient	O
should	O
follow-up	O
with	O
endodontist	O
after	O
discharge	O
from	O
rehab	O
to	O
evaluate	O
___	O
tooth.	O
-	O
EMERGENCY	O
CONTACT:	O
Husband	O
___	O
(___)	O
___.	O
___	O
___	O
(daughter)	O
___.	O
-	O
For	O
cough.	O
PCP	O
should	O
consider	O
further	O
workup	O
including	O
possibly	O
repeat	O
PFTs	O
if	O
patient	O
with	O
persistent	O
cough	O
after	O
improvement	O
in	O
cardiac	O
function.	O
SURGICAL	O
COURSE:	O
The	O
patient	O
was	O
brought	O
to	O
the	O
Operating	O
Room	O
on	O
___	O
where	O
the	O
patient	O
underwent	O
Aortic	O
Valve	O
Replacement	O
(#	O
21-mm	O
___	O
___	O
Ease	O
aortic	O
valve	O
bioprosthesis	O
(model	O
number	O
___,	O
serial	O
number	O
___.	O
Aortic	O
Endarterectomy	O
Aortic	O
patch	O
closure	O
with	O
bovine	O
pericardium.(Pericardium	O
data	O
--	O
reference	O
number	O
___,	O
lot	O
number	O
___	O
Dr.	O
___.	O
Please	O
refer	O
to	O
operative	O
report	O
for	O
further	O
surgical	O
details.	O
She	O
left	O
the	O
Operating	O
Room	O
on	O
titrated	O
Levophed	O
and	O
Propofol	O
drips.	O
Overall	O
the	O
patient	O
tolerated	O
the	O
procedure	O
well	O
and	O
post-operatively	O
was	O
transferred	O
to	O
the	O
CVICU	O
in	O
stable	O
condition	O
for	O
recovery	O
and	O
invasive	O
monitoring.	O
She	O
underwent	O
bronchoscopy	O
for	O
Right	O
Upper	O
Lobe	O
collapse,	O
mucous	O
plug	O
was	O
removed	O
and	O
lobe	O
re-expanded.	O
She	O
was	O
transfused	O
two	O
units	O
of	O
blood	O
for	O
a	O
hematocrit	O
of	O
28%.	O
The	O
patient	O
was	O
extubated	O
on	O
POD	O
1.	O
She	O
was	O
alert	O
and	O
slightly	O
confused.	B-Delirium
Hemodynamics	O
stabilized	O
and	O
she	O
was	O
weaned	O
from	O
vasopressor	O
support.	O
Beta	O
blocker	O
was	O
initiated	O
and	O
the	O
patient	O
was	O
gently	O
diuresed	O
toward	O
the	O
preoperative	O
weight.	O
All	O
lines	O
and	O
drains	O
were	O
discontinued	O
per	O
protocol.	O
She	O
remained	O
in	O
the	O
CVICU	O
for	O
close	O
monitoring	O
of	O
her	O
renal	O
function.	O
Her	O
Creatnine	O
peaked	O
at	O
2.4	O
was	O
trending	O
back	O
down	O
by	O
POD#	O
5	O
when	O
she	O
was	O
transferred	O
to	O
the	O
telemetry	O
floor	O
for	O
further	O
recovery.	O
The	O
patient	O
was	O
evaluated	O
by	O
the	O
physical	O
therapy	O
service	O
for	O
assistance	O
with	O
strength	O
and	O
mobility.	O
By	O
the	O
time	O
of	O
discharge	O
on	O
POD#	O
8	O
the	O
patient	O
was	O
ambulating	B-Independently_mobile
freely,	B-Independently_mobile
the	O
wound	O
was	O
healing	O
and	O
pain	O
was	O
controlled	O
with	O
oral	O
analgesics.	O
The	O
patient	O
was	O
discharged	O
to	O
___	O
___	O
in	O
___	O
in	O
good	O
condition	O
with	O
appropriate	O
follow	O
up	O
instructions.	O
Medications	O
on	O
Admission:	O
Toprol	O
XL	O
25	O
mg	O
p.o.	O
daily.	O
Lasix	O
20	O
mg	O
p.o.	O
daily.	O
K-Lor	O
20	O
mEq	O
p.o.	O
daily.	O
Motrin	O
800	O
mg	O
p.o.	O
daily.	O
Aspirin	O
81	O
mg	O
p.o.	O
daily.	O
Lipitor	O
20	O
mg	O
p.o.	O
daily.	O
Librium	O
10	O
mg	O
p.o.	O
daily.	O
___	O
1	O
tablet	O
p.o.	O
daily.	O
Detrol	O
LA	O
4	O
mg	O
p.o.	O
daily.	O
Multivitamin	O
1	O
tablet	O
p.o.	O
daily.	O
Vicodin	O
1	O
tablet	O
q.4	O
hours	O
p.r.n.	O
Extra	O
strength	O
Tylenol	O
as	O
needed.	O
Discharge	O
Medications:	O
1.	O
acetaminophen	O
325	O
mg	O
Tablet	O
Sig:	O
___	O
Tablets	O
PO	O
Q4H	O
(every	O
4	O
hours)	O
as	O
needed	O
for	O
temperature	O
>38.0.	O
2.	O
aspirin	O
81	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
One	O
(1)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
DAILY	O
(Daily).	O
3.	O
docusate	O
sodium	O
100	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
4.	O
atorvastatin	O
20	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
HS	O
(at	O
bedtime).	O
5.	O
tolterodine	O
2	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
6.	O
magnesium	O
hydroxide	O
400	O
mg/5	O
mL	O
Suspension	O
Sig:	O
Thirty	O
(30)	O
ML	O
PO	O
DAILY	O
(Daily)	O
as	O
needed	O
for	O
constipation.	B-Constipation
7.	O
heparin	O
(porcine)	O
5,000	O
unit/mL	O
Solution	O
Sig:	O
One	O
(1)	O
Injection	O
TID	O
(3	O
times	O
a	O
day).	O
8.	O
camphor-menthol	O
0.5-0.5	O
%	O
Lotion	O
Sig:	O
One	O
(1)	O
Appl	O
Topical	O
TID	O
(3	O
times	O
a	O
day)	O
as	O
needed	O
for	O
itchy	O
skin.	O
9.	O
ranitidine	O
HCl	O
150	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
10.	O
chlordiazepoxide	O
HCl	O
5	O
mg	O
Capsule	O
Sig:	O
Two	O
(2)	O
Capsule	O
PO	O
QHS	O
(once	O
a	O
day	O
(at	O
bedtime)).	O
11.	O
insulin	O
regular	O
human	O
100	O
unit/mL	O
Solution	O
Sig:	O
One	O
(1)	O
Injection	O
ASDIR	O
(AS	O
DIRECTED).	O
12.	O
bisacodyl	O
5	O
mg	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
Sig:	O
Two	O
(2)	O
Tablet,	O
Delayed	O
Release	O
(E.C.)	O
PO	O
DAILY	O
(Daily)	O
as	O
needed	O
for	O
constipation.	B-Constipation
13.	O
metolazone	O
2.5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
14.	O
potassium	O
chloride	O
20	O
mEq	O
Packet	O
Sig:	O
One	O
(1)	O
Packet	O
PO	O
DAILY	O
(Daily).	O
15.	O
metoprolol	O
succinate	O
50	O
mg	O
Tablet	O
Extended	O
Release	O
24	O
hr	O
Sig:	O
One	O
(1)	O
Tablet	O
Extended	O
Release	O
24	O
hr	O
PO	O
DAILY	O
(Daily).	O
16.	O
furosemide	O
10	O
mg/mL	O
Solution	O
Sig:	O
Four	O
(4)	O
Injection	O
DAILY	O
(Daily).	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Critical	O
aortic	O
stenosis-	O
Aortic	O
Valve	O
Replacement	O
PMH:	O
Moderate	O
to	O
severe	O
osteoarthritis	O
Likely	O
ischemic	O
cardiomyopathy,	O
EF	O
of	O
40-45%	O
Moderate	O
aortic	O
regurgitation	O
and	O
mild	O
MR	O
___	O
pulmonary	O
artery	O
hypertension	O
Hypertension	O
Hyperlipidemia	O
Scarlet	O
fever	O
at	O
the	O
age	O
of	O
___	O
Chronic	O
left	O
leg	O
edema	O
for	O
several	O
years,	O
after	O
3	O
attacks	O
of	O
cellulitis	O
___	O
years	O
apart	O
Anxiety	O
disorder	O
Chronic	O
kidney	O
disease	O
stage	O
III,	O
baseline	O
creatinine	O
1.2	O
Neuropathy	O
in	O
bilateral	O
hands	O
s/p	O
fall	B-Falls
___	O
years	O
ago	O
Chronic	O
urinary	O
urgency	O
Past	O
Surgical	O
History:	O
Bilateral	O
total	O
knee	O
replacement.	O
Left	O
shoulder	O
replacement.	O
Surgery	O
for	O
cervical	O
spondylosis.	O
Bilateral	O
Carpal	O
tunnel	O
surgery	O
Right	O
cataract	B-Visual_impairment
surgery	O
Appendectomy	O
Discharge	O
Condition:	O
Alert	O
and	O
oriented	B-Delirium
x	B-Delirium
3	B-Delirium
Deconditioned	O
Sternal	O
pain	O
managed	O
with	O
oral	O
analgesics	O
Sternal	O
Incision	O
-	O
healing	O
well,	O
no	O
erythema	O
or	O
drainage	O
Edema	O
Discharge	O
Instructions:	O
Please	O
shower	O
daily	O
including	O
washing	O
incisions	O
gently	O
with	O
mild	O
soap,	O
no	O
baths	O
or	O
swimming,	O
and	O
look	O
at	O
your	O
incisions	O
Please	O
NO	O
lotions,	O
cream,	O
powder,	O
or	O
ointments	O
to	O
incisions	O
Each	O
morning	O
you	O
should	O
weigh	O
yourself	O
and	O
then	O
in	O
the	O
evening	O
take	O
your	O
temperature,	O
these	O
should	O
be	O
written	O
down	O
on	O
the	O
chart	O
No	O
driving	O
for	O
approximately	O
one	O
month	O
and	O
while	O
taking	O
narcotics,	O
will	O
be	O
discussed	O
at	O
follow	O
up	O
appointment	O
with	O
surgeon	O
when	O
you	O
will	O
be	O
able	O
to	O
drive	O
No	O
lifting	O
more	O
than	O
10	O
pounds	O
for	O
10	O
weeks	O
Please	O
call	O
with	O
any	O
questions	O
or	O
concerns	O
___	O
**Please	O
call	O
cardiac	O
surgery	O
office	O
with	O
any	O
questions	O
or	O
concerns	O
___.	O
Answering	O
service	O
will	O
contact	O
on	O
call	O
person	O
during	O
off	O
hours**	O
Females:	O
Please	O
wear	O
bra	O
to	O
reduce	O
pulling	O
on	O
incision,	O
avoid	O
rubbing	O
on	O
lower	O
edge	O
Followup	O
Instructions:	O
___	O

